Intas And Axantia Ink Middle East Ranibizumab Distribution Deal

Product To Be Distributed Throughout Region By Axantia Subsidiaries

 
• By Chloe Kent

Intas has secured a distributor for its ranibizumab biosimilar throughout select countries in the Middle East, while Phase III trials continue ahead of anticipated US approval.

Map of the Middle East
Axantia will distribute Intas' ranibizumab across Saudi Arabia, Jordan, Iraq, Lebanon and GCC countries. • Source: Alamy

More from Deals

More from Business